NEA Management Company as of June 30, 2021
Portfolio Holdings for NEA Management Company
NEA Management Company holds 63 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bright Health Group | 48.8 | $3.7B | 218M | 17.16 | |
| Coursera (COUR) | 8.6 | $657M | 17M | 39.56 | |
| Cloudflare Cl A Com (NET) | 3.8 | $293M | 2.8M | 105.84 | |
| Crispr Therapeutics Namen Akt (CRSP) | 3.4 | $257M | 1.6M | 161.89 | |
| Desktop Metal Com Cl A (DM) | 2.9 | $223M | 19M | 11.50 | |
| Allakos (ALLK) | 2.4 | $185M | 2.2M | 85.37 | |
| Eargo | 2.3 | $180M | 4.5M | 39.91 | |
| Monte Rosa Therapeutics (GLUE) | 2.3 | $175M | 7.7M | 22.70 | |
| Ardelyx (ARDX) | 1.3 | $103M | 14M | 7.58 | |
| Bill Com Holdings Ord (BILL) | 1.3 | $103M | 561k | 183.18 | |
| Oyster Point Pharma | 1.3 | $102M | 5.9M | 17.19 | |
| Rhythm Pharmaceuticals (RYTM) | 1.3 | $96M | 4.9M | 19.58 | |
| Nkarta (NKTX) | 1.2 | $92M | 2.9M | 31.69 | |
| Metromile | 1.1 | $86M | 9.4M | 9.15 | |
| Adaptimmune Therapeutics Adr (ADAP) | 0.9 | $73M | 17M | 4.26 | |
| Mirum Pharmaceuticals (MIRM) | 0.9 | $72M | 4.2M | 17.29 | |
| Aurinia Pharmaceuticals (AUPH) | 0.9 | $67M | 5.2M | 12.96 | |
| CVRX (CVRX) | 0.9 | $66M | 2.4M | 28.00 | |
| Opendoor Technologies (OPEN) | 0.8 | $59M | 3.3M | 17.73 | |
| Annexon (ANNX) | 0.7 | $56M | 2.5M | 22.51 | |
| Trillium Therapeutics Com New | 0.7 | $56M | 5.7M | 9.70 | |
| Akouos | 0.7 | $54M | 4.3M | 12.55 | |
| Vistagen Therapeutics | 0.7 | $51M | 16M | 3.15 | |
| Casper Sleep | 0.7 | $51M | 6.2M | 8.24 | |
| Reneo Pharmaceuticals (RPHM) | 0.6 | $45M | 4.8M | 9.33 | |
| Galera Therapeutics (GRTX) | 0.6 | $43M | 4.4M | 9.83 | |
| Black Diamond Therapeutics (BDTX) | 0.5 | $42M | 3.4M | 12.19 | |
| Inozyme Pharma (INZY) | 0.5 | $42M | 2.4M | 17.04 | |
| Savara (SVRA) | 0.5 | $41M | 24M | 1.70 | |
| Affimed Therapeutics B V | 0.5 | $38M | 4.4M | 8.50 | |
| Upstart Hldgs (UPST) | 0.5 | $36M | 287k | 124.90 | |
| Bloom Energy Corp Com Cl A (BE) | 0.5 | $36M | 1.3M | 26.87 | |
| Verona Pharma Ads (VRNA) | 0.4 | $33M | 5.1M | 6.54 | |
| Imara | 0.4 | $32M | 4.0M | 7.90 | |
| Marker Therapeutics Ord | 0.4 | $30M | 11M | 2.79 | |
| Aveo Pharmaceuticals | 0.3 | $26M | 4.0M | 6.59 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.3 | $25M | 6.6M | 3.72 | |
| Mei Pharma Com New | 0.3 | $24M | 8.5M | 2.85 | |
| Genocea Biosciences (GNCAQ) | 0.3 | $24M | 10M | 2.34 | |
| Satsuma Pharmaceuticals Ord | 0.3 | $22M | 3.1M | 7.05 | |
| Glycomimetics (GLYC) | 0.3 | $21M | 9.1M | 2.32 | |
| Geron Corporation (GERN) | 0.2 | $19M | 14M | 1.41 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $19M | 992k | 18.62 | |
| Cti Biopharma Corp Com New | 0.2 | $18M | 7.1M | 2.50 | |
| Champions Oncology Com New (CSBR) | 0.2 | $18M | 1.7M | 10.28 | |
| Addex Therapeutics Sponsored Ads | 0.2 | $17M | 180k | 95.60 | |
| Synlogic | 0.2 | $17M | 4.2M | 3.89 | |
| Inventiva Sa Ads (IVA) | 0.2 | $14M | 1.0M | 13.64 | |
| Obseva Sa | 0.2 | $14M | 4.6M | 3.03 | |
| Trevi Therapeutics (TRVI) | 0.2 | $13M | 5.9M | 2.25 | |
| Strongbridge Biopharma Shs Usd | 0.2 | $12M | 4.1M | 2.97 | |
| Metacrine Ord | 0.2 | $12M | 3.1M | 3.80 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $11M | 2.4M | 4.59 | |
| Liquidia Technologies (LQDA) | 0.1 | $7.1M | 2.5M | 2.86 | |
| Trevena | 0.1 | $6.4M | 3.8M | 1.69 | |
| Lumos Pharma (LUMO) | 0.1 | $5.3M | 527k | 10.00 | |
| Regulus Therapeutics Com New | 0.1 | $5.2M | 6.5M | 0.81 | |
| Erytech Pharma Sa Adr | 0.0 | $3.0M | 625k | 4.83 | |
| Tracon Pharmaceuticals (TCON) | 0.0 | $2.2M | 347k | 6.49 | |
| Tempest Therapeutics (TPST) | 0.0 | $1.3M | 118k | 11.18 | |
| Vectivbio Hldg Ord Shs | 0.0 | $782k | 67k | 11.66 | |
| Akari Therapeutics Adr | 0.0 | $782k | 452k | 1.73 | |
| Viracta Therapeutics (VIRX) | 0.0 | $421k | 37k | 11.35 |
